Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.61 |
| ▸ | GSK3B | P49841 | 1/20 | 0.61 |
| ▸ | CCR6 | P51684 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10606752 | 0.82 | — | — | |
| Methacrylic Acid SCHEMBL19520638 | 0.80 | GSK3A (0.39) | GSK3AGSK3BCCR6 | |
| Benzene SCHEMBL28786769 | 0.78 | GSK3B (0.85) | GSK3AGSK3BCCR6MAPK1TDP1 | |
| Benzene SCHEMBL4231815 | 0.78 | GSK3B (0.85) | GSK3AGSK3BCCR6MAPK1TDP1 | |
| SCHEMBL10990 | 0.78 | — | — | |
| SCHEMBL33524954 | 0.78 | — | — | |
| SCHEMBL7021498 | 0.78 | — | — | |
| SCHEMBL1599522 | 0.78 | — | — | |
| SCHEMBL693917 | 0.78 | GSK3B (1.00) | GSK3AGSK3BCCR6MAPK1TDP1 | |
| SCHEMBL715867 | 0.78 | GSK3B (1.00) | GSK3AGSK3BCCR6MAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4602086-A1 | PHOTOCURABLE COMPOSITIONS FOR THREE-DIMENSIONAL INVESTMENT PATTERN CASTING AND USE THEREOF | Henkel AG & Co. KGaA (DE) | 2025-08-20 | — | — | EP | claimed |
| EP-4602083-A1 | PHOTOCURABLE COMPOSITIONS FOR ADDITIVE MANUFACTURING AND USE THEREOF | Henkel AG & Co. KGaA (DE) | 2025-08-20 | — | — | EP | claimed |
| US-20250250368-A1 | PHOTOCURABLE COMPOSITIONS FOR THREE-DIMENSIONAL INVESTMENT PATTERN CASTING AND USE THEREOF | HENKEL AG & CO. KGAA (DE) | 2025-08-07 | — | — | US | claimed |
| US-20250223460-A1 | PHOTOCURABLE COMPOSITIONS FOR ADDITIVE MANUFACTURING AND USE THEREOF | HENKEL AG & CO KGAA (DE) | 2025-07-10 | — | — | US | claimed |
| CN-118475626-A | Photocurable composition for additive manufacturing and use thereof | 汉高股份有限及两合公司 | 2024-08-09 | — | — | CN | claimed |
| WO-2024081115-A1 | PHOTOCURABLE COMPOSITIONS FOR THREE-DIMENSIONAL INVESTMENT PATTERN CASTING AND USE THEREOF | HENKEL AG & CO., KGAA (DE) | 2024-04-18 | — | — | WO | claimed |
| WO-2024081536-A1 | PHOTOCURABLE COMPOSITIONS FOR ADDITIVE MANUFACTURING AND USE THEREOF | HENKEL AG & CO., KGAA (DE) | 2024-04-18 | — | — | WO | claimed |
| CN-110452354-A | Reversible crosslink type thermoplastic polyurethane elastomer and preparation method thereof | Zhejiang huafeng thermoplastic polyurethane co ltd | 2019-11-15 | — | — | CN | claimed |
| EP-2749298-B1 | A 1,4,5-TRISUBSTITUTED1,2,3-TRIAZOLE MIMETIC OF RGD and/or OGP10-14, PROCESS TO OBTAIN IT AND USES THEREOF | UNIV PAIS VASCO (ES) | 2016-04-06 | — | — | EP | claimed |
| CN-105473169-A | Modified polyaryletherketone (PAEK) polymer and method for obtaining the same | UNIV DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA | 2016-04-06 | — | — | CN | claimed |
| US-20160053042-A1 | Modified Polyaryletherketone Polymer (Paek) and Process To Obtain It | UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA (ES) | 2016-02-25 | — | — | US | claimed |
| US-20150353509-A1 | A Compound 1,4,5-Trisubstituted1,2,3-Triazole, Process To Obtain And Uses Thereof | CENTRO DE INVESTIGACIÓN BIOMEDICA EN RED (ES) | 2015-12-10 | — | — | US | claimed |
| WO-2014102434-A1 | A 1,4,5-TRISUBSTITUTED1,2,3-TRIAZOLE MIMETIC OF RGD AND/OR OGP10-14, PROCESS TO OBTAIN IT AND USES THEREOF | UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA (ES) | 2014-07-03 | — | — | WO | claimed |
| EP-2749300-A1 | Modified polyaryletherketone polymer (PAEK) and process to obtain it | Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea (ES) | 2014-07-02 | — | — | EP | claimed |
| EP-2749298-A1 | A 1,4,5-TRISUBSTITUTED1,2,3-TRIAZOLE MIMETIC OF RGD and/or OGP10-14, PROCESS TO OBTAIN IT AND USES THEREOF | Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea (ES) | 2014-07-02 | — | — | EP | claimed |
| CN-121495283-A | High-strength high-resilience TPE thermoplastic elastomer and preparation method thereof | 湖南天头塑胶制品有限责任公司 | 2026-02-10 | — | — | CN | disclosed |
| EP-4602086-A1 | PHOTOCURABLE COMPOSITIONS FOR THREE-DIMENSIONAL INVESTMENT PATTERN CASTING AND USE THEREOF | Henkel AG & Co. KGaA (DE) | 2025-08-20 | — | — | EP | disclosed |
| WO-2005063895-A2 | THERMALLY-REVERSIBLE CROSSLINKING OF POLYMERS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| US-20040014933-A1 | Thermally re-mendable cross-linked polymers | NATIONAL SCIENCE FOUNDATION | 2004-01-22 | — | — | US | disclosed |
| US-6040115-A | THERMALLY IMAGING A THERMOSENSITIVE ELEMENT SUBSTRATE COATED WITH INK REPELLENT POLYMER COMPRISING SILICONE SEGMENTS AND HARD SEGMENTS TO FORM LITHOGRAPHIC PRINTING PLATE DEVELOPABLE WITHOUT WIPING | KODAK POLYCHROME GRAPHICS LLC (US) | 2000-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353509-A1 | A Compound 1,4,5-Trisubstituted1,2,3-Triazole, Process To Obtain And Uses Thereof | PTMS, BMP1, OCIAD1 | GSK3A 3597/4885GSK3B 3178/4885CCR6 2585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.